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Although amorphous solid dispersion is one of the most im-
portant formulation technologies for poorly soluble drugs [1],
the number of marketed oral amorphous formulations is still
limited. The lack of an accelerated study protocol for predict-
ing crystallization behavior of amorphous forms has been one
of the biggest issues that inhibit their wide use. Isothermal crys-
tallization behavior of pharmaceutical glasses is discussed in
this presentation with an eventual aim of predicting physical
stability of amorphous dosage forms.
Preparation of glass compounds and determination of crys-
tallinity were done by differential scanning calorimetry (DSC)
on a TA Q2000 (TA Instruments, New Castle, USA). Glasses were
prepared by quenching at 50 °C/min from above the melting
temperature, followed by annealing in temperature-controlled
ovens. The samples were stored in desiccator, in which hu-
midity was controlled by silica-gel or saturated salt solutions.
Annealing shorter than 48 hours under the dried condition was
performed in DSC. Thermal degradation was negligible for all
the compounds. As a comparison, freeze-drying using t-butyl
alcohol was also applied for preparing glass samples.
Crystallization behavior of glass materials is determined by
a balance of thermodynamic and kinetic factors, for which tem-
perature and local pressure are the dominating factors,
respectively [2]. Fig. 1 shows the time when the crystallinity
reached 10%, t10, as a function of the reduced temperature, Tg/T
[2].The data for the temperature-controlled compounds fell onto
the universal line at least above Tg, meaning that their initia-
tion time can be described as a function of only Tg if the
crystallization is governed by thermodynamics. The initia-
tion time for the pressure-controlled compounds was
significantly longer than that for the thermodynamically-
controlled ones because of their large energetic barrier for
nucleation. However, if the surface area was increased by em-
ploying freeze-drying method, the initiation time of the
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pressure-controlled compounds was shortened to be ex-
plained by the universal line as well [3]. It was also the case
for the samples stored under humid conditions. Thus, the uni-
versal line may be regarded as the worst case of crystallization
for the pressure-controlled compounds. Attempts to increase
stability of pharmaceutical glasses will also be discussed in the
presentation.
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Fig. 1 – 10% crystallization time (in min, t10) of model compounds as a function of Tg/T. q and FD represent quenched and
freeze-dried samples, respectively [2,3].
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